Laboratory Corp American Holdings (LH)

360.25
+29.08 (8.78%)
NYSE · Last Trade: Oct 28th, 4:30 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close331.17
Open344.55
Bid355.00
Ask364.00
Day's Range341.40 - 371.00
52 Week Range244.52 - 341.80
Volume1,796,713
Market Cap29.68B
PE Ratio (TTM)34.44
EPS (TTM)10.5
Dividend & Yield2.880 (0.80%)
1 Month Average Volume650,852

Chart

About Laboratory Corp American Holdings (LH)

Laboratory Corp American Holdings is a leading global life sciences company that offers comprehensive laboratory services, including diagnostic testing and drug development support. They operate advanced clinical laboratories that conduct a wide array of tests, specializing in areas such as genetics, infectious diseases, and routine screenings. The company also provides end-to-end solutions for the pharmaceutical and biotechnology industries, assisting in the development of new therapies and drugs through clinical trial testing and regulatory support. By leveraging cutting-edge technology and a vast network of resources, Laboratory Corp aims to improve healthcare outcomes and enhance patient care through accurate and timely laboratory results. Read More

News & Press Releases

Labcorp (LH) Q3 2026 Earnings Call Transcriptfool.com
Revenue grew 6.9% while operating margins expanded for a sixth consecutive quarter.
Via The Motley Fool · October 28, 2026
Labcorp (LH) stock trades up, here is why
What happened? Shares of healthcare diagnostics company Labcorp Holdings (NYSE:LH) jumped 10.3% in the afternoon session after the company reported third-qua...
Via StockStory · October 28, 2026
Labcorp Q3 Earnings Call Highlightsmarketbeat.com
Labcorp (NYSE:LH) reported third-quarter 2026 revenue growth, margin expansion and double-digit adjusted earnings-per-share growth, prompting the laboratory services company to raise the midpoint of its full-year revenue and earnings outlook. Revenue rose 7% to $3.8 billion in the quarter, while ad
Via MarketBeat · October 28, 2026
Labcorp Holdings (NYSE:LH) Posts In-Line Q3 Results and Raises Full-Year Outlookchartmill.com
Via Chartmill · October 28, 2026
Labcorp (NYSE:LH) Shares Slide on Q2 Revenue Miss Despite Earnings Beatchartmill.com
Via Chartmill · July 30, 2026
Labcorp’s (NYSE:LH) Q3 2026 sales beat estimates
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) reported Q3 2026 results beating Wall Street’s revenue expectations, with revenue up 6.9% year on y...
Via StockStory · October 28, 2026
Labcorp earnings: what to look for from LH
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) will be reporting earnings this Wednesday before market hours. Here’s what to expect. Labcorp met a...
Via StockStory · October 26, 2026
Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp
Transaction to benefit patients through expanded access and support Myriad’s strategic priorities
By Myriad Genetics, Inc. · Via GlobeNewswire · October 20, 2026
Q2 Earnings Outperformers: Labcorp (NYSE:LH) And The Rest Of The Testing & Diagnostics Services Stocks
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the testing & diagnostics services stocks, including Labcorp (NYSE:LH) and its peers. T...
Via StockStory · October 14, 2026
3 Low-Volatility Stocks That Concern Us
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. Luckily for ...
Via StockStory · September 29, 2026
Why Labcorp Holdings Stock Dropped Todayfool.com
The government thinks it's been overpaying Labcorp. They plan to stop doing that next year.
Via The Motley Fool · September 22, 2026
Discover the top S&P500 movers in Tuesday's pre-market session.chartmill.com
Via Chartmill · September 22, 2026
1 Mid-Cap Stock with Competitive Advantages and 2 That Underwhelm
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. Howe...
Via StockStory · September 14, 2026
1 Profitable Stock Worth Your Attention and 2 Facing Headwinds
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...
Via StockStory · September 10, 2026
3 Reasons LH is Risky and 1 Stock to Buy Instead
Over the past six months, Labcorp has been a great trade, beating the S&P 500 by 9.5%. Its stock price has climbed to $339.34, representing a healthy 20% inc...
Via StockStory · August 25, 2026
Labcorp CEO Adam Schechter Sells 4,669 Shares for $1.5 Millionfool.com
Schechter maintains a $33 million stake after this pre-scheduled sale under a Rule 10b5-1 plan.
Via The Motley Fool · August 12, 2026
5 Revealing Analyst Questions From Labcorp’s Q2 Earnings Call
Labcorp’s second quarter results were well received by the market, as the company delivered solid revenue growth and exceeded Wall Street’s non-GAAP profit e...
Via StockStory · August 6, 2026
Wondering what's happening in today's S&P500 pre-market session?chartmill.com
Via Chartmill · August 5, 2026
Labcorp (LH) Q2 2026 Earnings Call Transcriptfool.com
Specialty testing and Central Labs fueled revenue growth and margin expansion.
Via The Motley Fool · August 3, 2026
Labcorp Q2 Earnings Call Highlightsmarketbeat.com
Labcorp (NYSE:LH) reported second-quarter 2026 revenue growth, margin expansion and higher adjusted earnings, prompting the laboratory services company to raise the midpoint of its full-year revenue and adjusted EPS guidance. Revenue rose 5.8% year over year to $3.7 billion, while adjusted operatin
Via MarketBeat · July 31, 2026
LH Q2 Deep Dive: Specialty Testing and Consumer Growth Drive Guidance Increase
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 5.8% year on year to $3.73 billi...
Via StockStory · July 31, 2026
Labcorp (LH) Q2 2026 Earnings Call Transcriptfool.com
Specialty testing and Central Labs fueled revenue growth and margin expansion.
Via The Motley Fool · July 30, 2026
Labcorp (NYSE:LH) Reports Q2 CY2026 In Line With Expectations
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 5.8% year on year to $3.73 billi...
Via StockStory · July 30, 2026
Top S&P500 movers in Thursday's pre-market sessionchartmill.com
Via Chartmill · July 30, 2026
What To Expect From Labcorp’s (LH) Q2 Earnings
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) will be announcing earnings results this Thursday before market hours. Here’s what to look for. Lab...
Via StockStory · July 28, 2026